← Leaderboards
Maria Zajac-Kaye
University Of Florida
$1,699,653
Attributed
$1,699,653
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $342.1K · FY2016–20$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,699,653 · 1
By mechanism
R01$1,699,653 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- David G. Schatz$34,295,039
- Stephen D Anton$7,963,532
- Anne Elizabeth Cress$10,785,545
- Christiaan Leeuwenburgh$12,630,567
- Zhijian Qian$11,732,371
Others in their field
Top investigators on “Disease Resistance”
- Judith S. Currier · University Of California Los Angeles$243,950,834
- Gregory H Reaman · National Childhood Cancer Foundation$219,136,884
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$180,092,958
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Peter C Adamson · National Childhood Cancer Foundation$114,476,581
- Constance Ann Benson · University Of California, San Diego$111,247,564
Research focus
Disease ResistanceAffinityAdvanced DiseaseAdultAnticancer ResearchAttentionBaseBindingBiological MarkersAnalogCancer Cell LineCancer Gene MutationCancer ModelCancer TherapyCarbonCell CycleCell GrowthCell ProliferationClinical EffectivenessComplexCalorimetryDesignDimerDna Biosynthesis
Grant awards (5)
Studies on thymidylate synthase as a tumor-promoting oncogene for development of new allosteric inhibitors for cancer treatment$341,868
R01 · FY2020 · CA · contact PI
Studies on thymidylate synthase as a tumor-promoting oncogene for development of new allosteric inhibitors for cancer treatment$331,670
R01 · FY2019 · CA · contact PI
Studies on thymidylate synthase as a tumor-promoting oncogene for development of new allosteric inhibitors for cancer treatment$341,985
R01 · FY2018 · CA · contact PI
Studies on thymidylate synthase as a tumor-promoting oncogene for development of new allosteric inhibitors for cancer treatment$342,039
R01 · FY2017 · CA · contact PI
Studies on thymidylate synthase as a tumor-promoting oncogene for development of new allosteric inhibitors for cancer treatment$342,091
R01 · FY2016 · CA · contact PI